Literature DB >> 7714189

Detection of Yersinia pestis fraction 1 antigen with a fiber optic biosensor.

L K Cao1, G P Anderson, F S Ligler, J Ezzell.   

Abstract

A fiber optic biosensor was used to detect the fraction 1 (F1) antigen from Yersinia pestis, the etiologic agent of plague. The instrument employs an argon ion laser (514 nm) to launch light into a long-clad fiber and measures the fluorescence produced by an immunofluorescent complex formed in the evanescent wave region. This sensing area is a short section (12.5 cm) at the end of the optical fiber from which the cladding has been removed and in which the silica core has been tapered. Capture antibodies, which bind to F1 antigen, were immobilized on the core surface to form the basis of the sandwich fluoroimmunoassay. The ability to detect bound F1 antigen was provided by adding tetramethylrhodamine-labeled anti-plaque antibody to form fluorescent complexes. The evanescent wave has a limited penetration depth (< 1 lambda), which restricts detection of the fluorescent complexes bound to the fiber's surface. The direct correlation between the F1 antigen concentration and the signal provided an effective method for sample quantitation. This method achieved a high level of accuracy for determining F1 antigen concentrations from 50 to 400 ng/ml in phosphate-buffered saline, serum, plasma, and whole blood, with a 5-ng/ml limit of detection. Subsequent blind studies, which included serum samples from patients, yielded results in good agreement with measurements by enzyme-linked immunosorbent assay. A major advantage of the fiber optic biosensor is that results can be generated within minutes while isolating the user from hazardous samples. These factors favor development of this biosensor into a facile and rapid diagnostic device.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714189      PMCID: PMC227944          DOI: 10.1128/jcm.33.2.336-341.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

Review 1.  A decade of development in immunoassay methodology.

Authors:  J P Gosling
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

2.  Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis.

Authors:  E E BAKER; H SOMMER; L E FOSTER; E MEYER; K F MEYER
Journal:  J Immunol       Date:  1952-02       Impact factor: 5.422

3.  Use of thiol-terminal silanes and heterobifunctional crosslinkers for immobilization of antibodies on silica surfaces.

Authors:  S K Bhatia; L C Shriver-Lake; K J Prior; J H Georger; J M Calvert; R Bredehorst; F S Ligler
Journal:  Anal Biochem       Date:  1989-05-01       Impact factor: 3.365

4.  The conjugation of immunoglobulins with tetramethylrhodamine isothiocyanate. A comparison between the amorphous and the crystalline fluorochrome.

Authors:  L Amante; A Ancona; L Forni
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

5.  A monoclonal antibody for the specific diagnosis of plague.

Authors:  J E Williams; M K Gentry; C A Braden; G L Tyndal; P L Altieri; S Berman; D M Robinson
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  Use of an enzyme-linked immunosorbent assay to measure antigenaemia during acute plague.

Authors:  J E Williams; M K Gentry; C A Braden; F Leister; R H Yolken
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

7.  Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982.

Authors:  J E Williams; L Arntzen; G L Tyndal; M Isaäcson
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Detection of Clostridium botulinum toxin A using a fiber optic-based biosensor.

Authors:  R A Ogert; J E Brown; B R Singh; L C Shriver-Lake; F S Ligler
Journal:  Anal Biochem       Date:  1992-09       Impact factor: 3.365

  8 in total
  11 in total

Review 1.  Science, medicine, and the future. Near patient microbiological tests.

Authors:  S P Borriello
Journal:  BMJ       Date:  1999-07-31

Review 2.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Quantifying serum antiplague antibody with a fiber-optic biosensor.

Authors:  G P Anderson; K D King; L K Cao; M Jacoby; F S Ligler; J Ezzell
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  5' nuclease PCR assay to detect Yersinia pestis.

Authors:  J A Higgins; J Ezzell; B J Hinnebusch; M Shipley; E A Henchal; M S Ibrahim
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

5.  Molecualr Cloning of the capsular antigen F1 of Yersinia pestis in pBAD/gIII plasmid.

Authors:  A Jahanian-Najafabadi; M Soleimani; K Azadmanesh; E Mostafavi; K Majidzadeh-A
Journal:  Res Pharm Sci       Date:  2015 Jan-Feb

Review 6.  A review approaches to identify enteric bacterial pathogens.

Authors:  Jafar Amani; Seyed Ali Mirhosseini; Abbas Ali Imani Fooladi
Journal:  Jundishapur J Microbiol       Date:  2014-12-10       Impact factor: 0.747

7.  Plague in China 2014-All sporadic case report of pneumonic plague.

Authors:  Yun-Fang Li; De-Biao Li; Hong-Sheng Shao; Hong-Jun Li; Yue-Dong Han
Journal:  BMC Infect Dis       Date:  2016-02-19       Impact factor: 3.090

Review 8.  Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents - review.

Authors:  M Pohanka; P Skládal
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.629

9.  Development of a Cryptosporidium oocyst assay using an automated fiber optic-based biosensor.

Authors:  Marianne F Kramer; Graham Vesey; Natasha L Look; Ben R Herbert; Joyce M Simpson-Stroot; Daniel V Lim
Journal:  J Biol Eng       Date:  2007-10-10       Impact factor: 4.355

10.  Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples.

Authors:  Hui-Ling Hsu; Chuan-Chang Chuang; Chung-Chih Liang; Der-Jiang Chiao; Hsueh-Ling Wu; Yu-Ping Wu; Feng-Ping Lin; Rong-Hwa Shyu
Journal:  BMC Infect Dis       Date:  2018-08-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.